CAM
MEDP icon

Claret Asset Management’s Medpace MEDP Stock Holding History

Claret Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Sell
422
-313
-43% -$144K 0.02% 418
2026
Q1 		$353K Hold
735
– – 0.04% 157
2025
Q4 		$413K Sell
735
-2
-0.3% -$1.14K 0.05% 127
2025
Q3 		$379K Sell
737
-11
-1% -$4.8K 0.05% 126
2025
Q2 		$235K Buy
+748
New +$225K 0.03% 248
2024
Q3 		– Sell
-496
Closed -$205K – 344
2024
Q2 		$205K Sell
496
-88
-15% -$34.8K 0.04% 192
2024
Q1 		$237K Buy
+584
New +$205K 0.04% 146

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Claret Asset Management's MEDP Position: Q2 2026 in Review

Claret Asset Management reduced its Medpace (MEDP) stake by 43% in Q2 2026, selling an estimated $144K and leaving 422 shares worth $224K. The position accounts for 0.02% of the portfolio, ranked #418.

Claret Asset Management first reported a position in MEDP in Q1 2024 and has held it in 7 quarters since. The position peaked at $413K in Q4 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Claret Asset Management held 422 shares of Medpace worth $224K as of Q2 2026.
  • Claret Asset Management sold 313 Medpace shares in Q2 2026, an estimated $144K.
  • Medpace made up 0.02% of Claret Asset Management's portfolio in Q2 2026, its #418 holding.
  • Claret Asset Management first reported a position in Medpace in Q1 2024 and has held it in 7 quarters since.
  • Claret Asset Management's Medpace position peaked at $413K in Q4 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.